research on retatrutide Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Retatrutide: What It Is &

Non-Alcoholic Fatty Liver Disease (NAFLD) Hepatic lipid accumulation driven by insulin resistance and impaired lipid export

Our team recommends writing this down

Second Nature Second Nature charges an all-inclusive monthly fee covering medication, delivery, dietitian coaching, app access, and peer support: Wegovy programme: ~99-249 per month depending on dose Mounjaro programme: pricing available on the Second Nature website Non-medication programme: from 33/month WeightWatchers WeightWatchers UK GLP-1 programme is a membership fee for the behavioural support only

Shifting GLP-1s from a one-time prescription to a continuous care model, opt-ins receive a pre-visit screening, structured consultations and oversight, and evidence-based support via its AI healthcare agent

While GLP-1s can reduce appetite and cravings, pairing treatment with supportive lifestyle habits and following nutrition tips from your clinician often makes changes feel more noticeable and sustainable

Further, it lessened the risk of death from all causes by 15% and notably diminished the likelihood of fatal myocardial infarction by 40% [30]